Abstract
Background
Retinal pigment epithelial (RPE) cells and choroidal microvascular endothelial cells (CECs) are the main cells involved in choroidal neovascularization (CNV), and hypoxia plays an important role in CNV formation via hypoxia inducible factor 1 (HIF-1). Our aim was to evaluate the role of HIF-1 in human RPE cells with regard to proliferation, migration and tube formation of CECs under hypoxia.
Methods
RPE cells were cultured under chemical hypoxia induced by 200 μM CoCl2, and RNA interference (RNAi) technique was used to knock down HIF-1α gene in RPE cells. mRNA and protein expression of HIF-1α and VEGF in RPE cells were investigated by real-time RT-PCR and Western blot. Three kinds of coculture models were used to observe the effects of RPE cells transfected by short hairpin RNA (shRNA)-expressing plasmid DNA (pDNA) (pshHIF-1α) on the proliferation, migration and tube formation of CECs respectively.
Results
Transfection of shRNA-expressing pDNA targeting HIF-1α to RPE cells resulted in the knock down of HIF-1α gene and reduction of the corresponding mRNA and protein of HIF-1α and VEGF under hypoxia. Consequently, the proliferation, migration and tube formation of CECs were significantly inhibited by the knocked-down RPE cells compared with the control in the coculture system. The proliferation rates of CECs decreased by 40.2%, 36.6% and 36.8% on days 3, 4 and 5 respectively. Migration reduced by 49.6% at 5 h, and tube formation decreased by 40.4% at 48 h.
Conclusion
RNAi of HIF-1α in RPE cells can inhibit angiogenesis in vitro and provide a possible strategy for treatment of choroidal neovascularization diseases by targeting HIF-1α.
Similar content being viewed by others
References
Lambooij AC, van Wely KH, Lindenbergh-Kortleve DJ, Kuijpers RW, Kliffen M, Mooy CM (2003) Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 44:2192–2198, Medline. DOI 10.1167/iovs.02–0410
Schlingemann RO (2004) Role of growth factors and the wound healing response in age-related macular degeneration. Graefe Arch Clin Exp Ophthalmol 242:91–101, Medline. DOI 10.1007/s00417–003–0828–0
Zhang P, Wang Y, Hui Y, Hu D, Wang H, Zhou J, Du H (2007) Inhibition of VEGF expression by targeting HIF-1 alpha with small interference RNA in human RPE cells. Ophthalmologica 221:411–417, Medline. DOI 10.1159/000107502
Penfold PL, Madigan MC, Gillies MC, Provis JM (2001) Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 20:385–414, Medline. DOI 10.1016/S1350–9462(00)00025–2
Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859–870, Medline. DOI 10.1097/01.iae.0000242842.14624.e7
Kinose F, Roscilli G, Lamartina S, Anderson KD, Bonelli F, Spence SG, Ciliberto G, Vogt TF, Holder DJ, Toniatti C, Thut CJ (2005) Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor. Mol Vis 11:366–373
Aiello LP (2005) Angiogenic pathways in diabetic retinopathy. N Engl J Med 353:839–841, Medline. DOI 10.1056/NEJMe058142
Ruiz-Moreno JM, Montero JA, Zarbin MA (2007) Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome. Retina 27:458–461, Medline. DOI 10.1097/IAE.0b013e318030c77c
Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y (2008) Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy. Graefe Arch Clin Exp Ophthalmol 246:339–344, Medline. DOI 10.1007/s00417–007–0667–5
Bracken CP, Fedele AO, Linke S, Balrak W, Lisy K, Whitelaw ML, Peet DJ (2006) Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment. J Biol Chem 281:22575–22585, Medline. DOI 10.1074/jbc.M600288200
Check E (2005) A crucial test. Nat Med 11:243–244, Medline. DOI 10.1038/nm0305–243
Murata M, Takanami T, Shimizu S, Kubota Y, Horiuchi S, Habano W, Ma JX, Sato S (2006) Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF). Curr Eye Res 31:171–180, Medline. DOI 10.1080/02713680500514636
Wang YS, Hui YN, Wiedemann P (2002) Role of apoptosis in the cytotoxic effect mediated by daunorubicin in cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther 18:377–387, Medline. DOI 10.1089/10807680260218542
Wang YS, Eichler W, Friedrichs U, Yafai Y, Hoffmann S, Yasukawa T, Hui YN, Wiedemann P (2005) Impact of endostatin on bFGF-induced proliferation, migration, and matrix metalloproteinase-2 expression/secretion of bovine choroidal endothelial cells. Curr Eye Res 30:479–489, Medline. DOI 10.1080/02713680590959358
Geisen P, McColm JR, Hartnett ME (2006) Choroidal endothelial cells transmigrate across the retinal pigment epithelium but do not proliferate in response to soluble vascular endothelial growth factor. Exp Eye Res 82:608–619, Medline. DOI 10.1016/j.exer.2005.08.021
Peterson LJ, Wittchen ES, Geisen P, Burridge K, Hartnett ME (2007) Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res 84:737–744, Medline. DOI 10.1016/j.exer.2006.12.012
Slomiany MG, Rosenzweig SA (2004) Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. Am J Physiol Cell Physiol 287:C746–753, Medline. DOI 10.1152/ajpcell.00568.2003
Slomiany MG, Rosenzweig SA (2006) Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion. J Pharmacol Exp Ther 318:666–675, Medline. DOI 10.1124/jpet.106.104158
Forooghian F, Razavi R, Timms L (2007) Hypoxia-inducible factor expression in human RPE cells. Br J Ophthalmol 91:1406–1410, Medline. DOI 10.1136/bjo.2007.123125
Mojsilovic-Petrovic J, Callaghan D, Cui H, Dean C, Stanimirovic DB, Zhang W (2007) Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation 4:12, Medline. DOI 10.1186/1742–2094–4–12
Newcomb EW, Lukyanov Y, Schnee T, Ali MA, Lan L, Zagzag D (2006) Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug. Int J Oncol 28:1121–1130
Fan W, Zheng JJ, McLaughlin BJ (2002) An in vitro model of the back of the eye for studying retinal pigment epithelial-choroidal endothelial interactions. In Vitro Cell Dev Biol Anim 38:228–234, Medline. DOI 10.1290/1071–2690(2002)038
Mizuno T, Nagao M, Yamada Y, Narikiyo M, Ueno M, Miyagishi M, Taira K, Nakajima Y (2006) Small interfering RNA expression vector targeting hypoxia-inducible factor 1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers. Cancer Gene Ther 13:131–140, Medline. DOI 10.1038/sj.cgt.7700871
Jensen RL, Ragel BT, Whang K, Gillespie D (2006) Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol 78:233–247, Medline. DOI 10.1007/s11060–005–9103-z
Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ (2003) Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 9:210–216
Tolentino MJ, Brucker AJ, Fosnot J, Ying GS, Wu IH, Malik G, Wan S, Reich SJ (2004) Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina 24:132–138, Medline. DOI 10.1097/00006982–200402000–00018
Campochiaro PA (2006) Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther 13:559–562, Medline. DOI 10.1038/sj.gt.3302653
Forooghian F, Das B (2007) Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Am J Ophthalmol 144:761–768, Medline. DOI 10.1016/j.ajo.2007.07.022
Schwesinger C, Yee C, Rohan RM, Joussen AM, Fernandez A, Meyer TN, Poulaki V, Ma JJ, Redmond TM, Liu S, Adamis AP, D’Amato RJ (2001) Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 158:1161–1172
Holekamp NM, Bouck N, Volpert O (2002) Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 134:220–227, Medline. DOI 10.1016/S0002–9394(02)01549–0
Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA (2006) Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82:99–110, Medline. DOI 10.1016/j.exer.2005.05.007
Zhang SX, Ma JX (2007) Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Prog Retin Eye Res 26:1–37, Medline. DOI 10.1016/j.preteyeres.2006.09.002
Notari L, Miller A, Martinez A, Amaral J, Ju M, Robinson G, Smith LE, Becerra SP (2005) Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 46:2736–2747, Medline. DOI 10.1167/iovs.04–1489
Spaide RF (2006) Rationale for combination therapies for choroidal neovascularization. Am J Ophthalmol 141:149–156, Medline. DOI 10.1016/j.ajo.2005.07.025
Saishin Y, Silva RL, Saishin Y, Kachi S, Aslam S, Gong YY, Lai H, Carrion M, Harris B, Hamilton M, Wei L, Campochiaro PA (2005) Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum Gene Ther 16:473–478, Medline. DOI 10.1089/hum.2005.16.473
Acknowledgments
This work was supported by grants from National Natural Science Foundation of China (No.30371516, 30672291). The project was sponsored partly by the equipment donation from the Alexander Von Humboldt Foundation in Germany (to YS Wang, V8151/02085).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhao, W., Wang, YS., Hui, YN. et al. Inhibition of proliferation, migration and tube formation of choroidal microvascular endothelial cells by targeting HIF-1α with short hairpin RNA-expressing plasmid DNA in human RPE cells in a coculture system. Graefes Arch Clin Exp Ophthalmol 246, 1413–1422 (2008). https://doi.org/10.1007/s00417-008-0858-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0858-8